Akebia Therapeutics Inc. buy BTIG Research
Start price
02.12.25
/
50%
€1.27
Target price
02.12.26
€4.31
Performance (%)
8.95%
Price
07:31
?
Summary
This prediction is currently active. With a performance of 8.95%, the BUY prediction by BTIG_Research for Akebia Therapeutics Inc. is trending in the right direction. This prediction currently runs until 02.12.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Akebia Therapeutics Inc. | 7.834% |
| iShares Core DAX® | 1.659% |
| iShares Nasdaq 100 | 0.381% |
| iShares Nikkei 225® | 2.102% |
| iShares S&P 500 | 0.221% |
Comments by BTIG_Research for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics (NASDAQ:AKBA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $5.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by BTIG_Research for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.93
29.10.25
29.10.25
€4.29
29.10.26
29.10.26
-28.01%
07:31
07:31
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
29.11.23
29.11.23
€3.64
29.11.24
29.11.24
122.78%
30.11.24
30.11.24